AWM
MED icon

Abound Wealth Management’s Medifast MED Stock Holding History

Abound Wealth Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$115 – 1260
2024
Q1 		$115 Hold
3
– – ﹤0.01% 1267
2023
Q4 		$202 Hold
3
– – ﹤0.01% 1269
2023
Q3 		$225 Hold
3
– – ﹤0.01% 1084
2023
Q2 		$277 Buy
+3
New +$267 ﹤0.01% 1084

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Abound Wealth Management's MED Position: Q2 2024 in Review

Abound Wealth Management sold out of Medifast (MED) in Q2 2024, closing a stake of 3 shares — an estimated $115 sold.

Abound Wealth Management first reported a position in MED in Q2 2023 and held it in 4 quarters. The position peaked at $277 in Q2 2023. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Abound Wealth Management reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Abound Wealth Management sold 3 Medifast shares in Q2 2024, an estimated $115.
  • Abound Wealth Management first reported a position in Medifast in Q2 2023 and held it in 4 quarters.
  • Abound Wealth Management's Medifast position peaked at $277 in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Abound Wealth Management's 13F filing for Q2 2024, filed 9 Aug 2024.